Graduate Program in Comparative Medicine and Integrative Biology, College of Veterinary Medicine, Michigan State University, 784 Wilson Road, East Lansing, MI 48824, USA; Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, 784 Wilson Road, East Lansing, MI 48824, USA.
Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, 784 Wilson Road, East Lansing, MI 48824, USA; Veterinary Diagnostic Laboratory, 4125 Beaumont Road, Building 0215, Lansing, MI 48910, USA.
Virus Res. 2019 Apr 15;264:56-67. doi: 10.1016/j.virusres.2019.02.013. Epub 2019 Feb 20.
Feline herpesvirus-1 (FHV-1) infection occurs worldwide and is a leading cause of respiratory and ocular diseases in cats. Current vaccines reduce the severity of symptoms but do not prevent infection and, therefore, do not provide defense against an establishment of latency and reactivation. We hypothesize that immunomodulation of FHV-1 is the cause of lack in protection and that deletion of virulence/immune modulatory genes of FHV-1 will enhance safety and immunogenicity. Our objective was to use feline respiratory epithelial cell (FREC) cultures to define in vitro growth characteristics and immunomodulation resulting from infection of FRECs with the virulent FHV-1 strain C27 (WT) and glycoprotein C-deletion (gC-), glycoprotein E-deletion (gE-), serine/threonine protein kinase-deletion (PK-), as well as gE and thymidine kinase-double-deletion (gE-TK-) mutants generated by bacterial artificial chromosome mutagenesis. Differentiated FRECs were mock inoculated or inoculated with WT, gC-, gE-, PK-, or gE-TK- mutants. Virus titration and real-time quantitative PCR assays were performed on samples collected at 1 hpi followed by 24 h intervals between 24 and 96 hpi to determine growth kinetics. Real-time PCR was used to quantitate IFNα, TNFα, IL-1β, IL-10, and TGFβ-specific mRNA levels. Immunoassays were performed to measure the protein levels of subsets of cytokines/chemokines secreted by FRECs. Inoculation of FRECs with gE-TK- resulted in significantly lower end-point titers than inoculation with WT or gE-. Both PK- and gC- inoculated FRECs also produced significantly lower end-point titers at 96 hpi than WT. Overall, intracellular virus titers were higher than those of extracellular virus. PCR results for viral DNA paralleled the virus titration results. Further, in contrast to WT inoculation, an increase in IFNα and IL-10 mRNA expression was not observed following inoculation with gE-TK- and PK-, but inoculation with gE-TK- and PK- did result in increased TGFβ expression in FRECs compared to responses following infection with WT. Moreover, gE-TK- and PK- blocked the inhibition of IL-8 and neutrophil chemoattractant (KC), which was observed following inoculation with WT. In summary, the results obtained in FRECs may be used to predict the safety and immunogenicity characteristics of these mutants in vivo. Our study highlights the value of the FREC system for studying replication kinetics/immune modulation factors of FHV-1 and screening prospective vaccine candidates before their use in experimental cats.
猫疱疹病毒 1 型(FHV-1)感染遍布全球,是猫呼吸道和眼部疾病的主要病因。目前的疫苗虽能减轻症状的严重程度,但不能预防感染,因此不能提供对潜伏期和再激活的防御。我们假设 FHV-1 的免疫调节是缺乏保护的原因,并且 FHV-1 的毒力/免疫调节基因缺失将提高安全性和免疫原性。我们的目标是使用猫呼吸道上皮细胞(FREC)培养物来定义由强毒 FHV-1 株 C27(WT)和糖蛋白 C 缺失(gC-)、糖蛋白 E 缺失(gE-)、丝氨酸/苏氨酸蛋白激酶缺失(PK-)、以及通过细菌人工染色体诱变产生的 gE 和胸苷激酶双缺失(gE-TK-)突变体感染 FRECs 后的体外生长特征和免疫调节。分化的 FRECs 被模拟接种或接种 WT、gC-、gE-、PK-或 gE-TK-突变体。在感染后 1 小时(hpi)采集样本,然后在 24 至 96 hpi 之间每隔 24 小时进行病毒滴定和实时定量 PCR 检测,以确定生长动力学。使用实时 PCR 定量测定 IFNα、TNFα、IL-1β、IL-10 和 TGFβ 特异性 mRNA 水平。免疫测定用于测量 FRECs 分泌的细胞因子/趋化因子亚群的蛋白水平。与 WT 或 gE-相比,gE-TK-接种的 FRECs 的终点滴度明显降低。PK-和 gC-接种的 FRECs 在 96 hpi 时的终点滴度也明显低于 WT。总体而言,细胞内病毒滴度高于细胞外病毒滴度。病毒 DNA 的 PCR 结果与病毒滴定结果平行。此外,与 WT 接种相比,gE-TK-和 PK-接种后未观察到 IFNα和 IL-10 mRNA 表达增加,但与 WT 感染相比,gE-TK-和 PK-接种导致 FRECs 中 TGFβ 表达增加。此外,gE-TK-和 PK-阻断了 WT 接种后观察到的 IL-8 和中性粒细胞趋化因子(KC)的抑制。总之,在 FRECs 中获得的结果可用于预测这些突变体在体内的安全性和免疫原性特征。我们的研究强调了 FREC 系统在研究 FHV-1 复制动力学/免疫调节因子以及在实验猫中使用之前筛选潜在疫苗候选物方面的价值。